Myo-inositol and prostaglandins reverse the glucose inhibition of neural tube fusion in cultured mouse embryos.
Neural tube defects in infants of diabetic mothers constitute an important and frequent cause of neonatal mortality/morbidity and long-term chronic handicaps. The mechanism by which normal neural tube fusion occurs is not known. The failure of rostral neural tube fusion seen in mouse embryos incubated in the presence of excess-D-glucose can be significantly prevented by the supplementation of myo-inositol to the culture medium. This protective effect of myo-inositol is reversed by indomethacin, an inhibitor of arachidonic acid metabolism leading to prostaglandin synthesis. Prostaglandin E2 added to the culture medium completely protects against the glucose-induced neural tube defect. These data suggest that the failure of neural tube fusion seen in diabetic embryopathy is mediated through a mechanism involving abnormalities in both the myo-inositol and arachidonic acid pathways, resulting in a functional deficiency of prostaglandins at a critical time of neural tube fusion.
Baker
L
L
Department of Pediatrics, School of Medicine, University of Pennsylvania, Philadelphia.
Piddington
R
R
Goldman
A
A
Egler
J
J
Moehring
J
J
D000818:Animals; D015232:Dinoprostone / Q000494:pharmacology; D004622:Embryo, Mammalian / Q000187:drug effects*; D005947:Glucose / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D007294:Inositol / Q000494:pharmacology*; D051379:Mice; D008815:Mice, Inbred Strains; D009436:Neural Tube Defects / Q000517:prevention & control*; D011453:Prostaglandins / Q000494:pharmacology*
D011453:Prostaglandins; D007294:Inositol; D005947:Glucose; D015232:Dinoprostone; D007213:Indomethacin